TPG (TPG) and Blackstone (BX) made an approach to take Hologic (HOLX) private in a deal that would value the company at $16.3B-$16.7B, including debt, The Financial Times’ Oliver Barnes and Antoine Gara report. People familiar with the matter say that Hologic, in recent weeks, rejected the nonbinding proposal, but add that there is still a chance deal talks could be renewed.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HOLX:
- Hologic trading halted, volatility trading pause
- Hologic price target lowered to $70 from $77 at Stephens
- Hologic price target lowered to $65 from $77 at Morgan Stanley
- Hologic’s Hold Rating: Balancing Growth in Diagnostics with Challenges in Breast Health and Geopolitical Pressures
- Hologic’s Financial Outlook: Hold Rating Amid Revenue Decline and Tariff Challenges